BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 20370586)

  • 1. Noninvasive fetal RhD genotyping from maternal blood.
    Kolialexi A; Tounta G; Mavrou A
    Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects.
    Daniels G; Finning K; Martin P; Massey E
    Prenat Diagn; 2009 Feb; 29(2):101-7. PubMed ID: 19085963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal RhD genotyping by analysis of maternal blood. A case report.
    Tóth T; Papp C; Tóth-Pál E; Nagy B; Papp Z
    J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal blood group genotyping: present and future.
    Daniels G; Finning K; Martin P; Summers J
    Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
    Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M
    BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
    Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
    Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G; Finning K; Martin P; Summers J
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic analysis of the fetus using maternal blood].
    Costa JM; Gautier E; Benachi A
    Gynecol Obstet Fertil; 2004; 32(7-8):646-50. PubMed ID: 15450264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fetal RHD genotyping by PCR using plasma from D negative pregnant women].
    Achargui S; Tijane M; Benchemsi N
    Transfus Clin Biol; 2011 Feb; 18(1):13-9. PubMed ID: 21190884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
    Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
    Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.
    Zhou L; Thorson JA; Nugent C; Davenport RD; Butch SH; Judd WJ
    Am J Obstet Gynecol; 2005 Dec; 193(6):1966-71. PubMed ID: 16325598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive fetal RHD genotyping by maternal plasma with capillary electrophoresis.
    Kimura M; Sato C; Hara M; Ishihara O; Ikebuchi K
    Transfusion; 2008 Jun; 48(6):1156-63. PubMed ID: 18422850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the RhD genotype in fetuses at risk for RhD hemolytic disease.
    Spence WC; Maddalena A; Demers DB; Bick DP
    Obstet Gynecol; 1995 Feb; 85(2):296-8. PubMed ID: 7824249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
    Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
    J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.
    Geifman-Holtzman O; Grotegut CA; Gaughan JP
    Am J Obstet Gynecol; 2006 Oct; 195(4):1163-73. PubMed ID: 17000250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.